|
KMID : 1134120230260010086
|
|
Journal of Breast Cancer
2023 Volume.26 No. 1 p.86 ~ p.91
|
|
|
Biomarkers That Predict an Unclear Benefit From Adjuvant Trastuzumab, Pertuzumab and Pembrolizumab When Those Same Drugs Were Given Neoadjuvantly
|
|
Steven Sorscher
|
|
|
Abstract
|
|
|
|
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|